Abstract: The present invention discloses a sector dual-resonant dipole antenna. Radiation elements of the antenna are two identical sector patches. Two identical rectangular notches can be symmetrically arranged or two identical tuning stubs can be symmetrically loaded on the sector patches at positions deviating from the central axis of the two sector patches. Exciting points are symmetrically arranged on sides of the sector patches close to a central axis. The present invention realizes a wide beamwidth radiation characteristic through a two-dimensional sectorial resonator, and then the notches are arranged or the tuning stubs are loaded at appropriate positions of two arms of the sectorial resonator, and thereby a dual-resonant characteristic can be realized within a working band.

Abstract: The present invention discloses a triple-resonant null frequency scanning antenna, which belongs to the technical fields of the Internet of Things and microwave. The triple-resonant null frequency scanning antenna comprises a circular sector magnetic dipole arranged on a medium substrate, and rectangular notches are symmetrically arranged on a sector patch of the circular sector magnetic dipole. The circular sector magnetic dipole is fixed on the medium substrate by a second shorting pin and third shorting pins, an flared angle of the circular sector magnetic dipole is a first central angle, and two third shorting pins are present and are symmetrically arranged on both sides of the angular bisector of the first central angle.

Abstract: The present invention relates to series of peptidomimetic compounds selectively targeting CBX8 of polycomb chromobox protein homolog proteins. Pharmaceutical compositions of those compounds and methods of using them in the treatment of diseases involved CBX8 pharmacology, including various cancers and leukemia, by administering therapeutically effective amounts of such compound alone or together with other therapeutics, are within the scope of this disclosure.

Abstract: The present invention relates to series of peptidomimetic compounds selectively targeting CBX8 of polycomb chromobox protein homolog proteins. Pharmaceutical compositions of those compounds and methods of using them in the treatment of diseases involved CBX8 pharmacology, including various cancers and leukemia, by administering therapeutically effective amounts of such compound alone or together with other therapeutics, are within the scope of this disclosure.